Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Drug Costs"" wg kryterium: Temat


Tytuł:
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab.
Autorzy:
Heine RJSD; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Thielen FW; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, Rotterdam, The Netherlands.
van Leeuwen RWF; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Rotterdam, The Netherlands.
Franken MG; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Uyl-de Groot CA; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 01; Vol. 19 (2), pp. e0293264. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Drug Costs*
Neoplasms*/drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; Antibodies, Monoclonal/therapeutic use ; Cost Control
Czasopismo naukowe
Tytuł:
The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis.
Autorzy:
Wang X; School of Health Policy and Management, Nanjing Medical University, No.101 Longmian Avenue, Jiangning District, Nanjing, Jiangsu, P.R. China, 211166.; Department of Science and Technology, Wuxi No.2 People's Hospital, Wuxi, China.
He X; School of Health Policy and Management, Nanjing Medical University, No.101 Longmian Avenue, Jiangning District, Nanjing, Jiangsu, P.R. China, 211166.; Wuxi Xinwu District Center for Health Promotion and Education, Wuxi, China.
Zhang P; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Zhang M; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Ma R; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Dai R; National Institute of Drug Clinical Trials, the Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, China. .
Li X; School of Health Policy and Management, Nanjing Medical University, No.101 Longmian Avenue, Jiangning District, Nanjing, Jiangsu, P.R. China, 211166. .; School of Pharmacy, Nanjing Medical University, Nanjing, China. .; Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China. .
Pokaż więcej
Źródło:
International journal for equity in health [Int J Equity Health] 2023 Sep 28; Vol. 22 (1), pp. 200. Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Costs*
Health Expenditures*
Humans ; Interrupted Time Series Analysis ; Cost Savings ; Health Policy ; Drugs, Generic
Czasopismo naukowe
Tytuł:
A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China.
Autorzy:
Xie L; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Ding L; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Tang L; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Yang Z; Department of Neonatology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Wu D; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Wang W; Children's Hospital of Soochow University, Medical College of Soochow University, Soochow University, Suzhou, China.
Mao J; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Shi L; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Liu C; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Duan L; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Xu J; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Zhou Q; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China. .
Sun J; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China. .
Ding X; Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China. .
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Jul 19; Vol. 23 (1), pp. 771. Date of Electronic Publication: 2023 Jul 19.
Typ publikacji:
Journal Article
MeSH Terms:
Vancomycin*/administration & dosage
Vancomycin*/economics
Vancomycin*/therapeutic use
Linezolid*/administration & dosage
Linezolid*/economics
Linezolid*/therapeutic use
Anti-Bacterial Agents*/administration & dosage
Anti-Bacterial Agents*/economics
Anti-Bacterial Agents*/therapeutic use
Neonatal Sepsis*/drug therapy
Methicillin-Resistant Staphylococcus aureus*/genetics
Methicillin-Resistant Staphylococcus aureus*/isolation & purification
Drug Costs*
Cost-Effectiveness Analysis ; Humans ; Male ; Female ; Infant ; Coagulase/genetics ; Retrospective Studies ; Treatment Outcome ; China
Czasopismo naukowe
Tytuł:
What condition leads to an unreasonable pharmaceutical price? Impact research on the effect of medical service provision on pharmaceutical price regulation based on fuss-set QCA.
Autorzy:
Fang LB; School of Journalism, Fudan University, Shanghai, China.
Wang X; School of Management, Fudan University, Shanghai, China.
Tang L; School of Journalism, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 13; Vol. 18 (4), pp. e0284129. Date of Electronic Publication: 2023 Apr 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Drug Costs*
Economics, Pharmaceutical*
Pharmaceutical Preparations
Czasopismo naukowe
Tytuł:
Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis.
Autorzy:
Li C; Department of Social Medicine, School of Health Management, Harbin Medical University, Heilongjiang, China.; Department of Material management, Fourth Affiliated Hospital, Harbin Medical University, Heilongjiang, China.
Zhu J; Department of Social Medicine, School of Health Management, Harbin Medical University, Heilongjiang, China.; Department of Epidemiology and Public Health, University College London, London, UK.; Centre for Health Economics and Policy Innovation, Department of Economics and Public Policy, Imperial Business School, London, UK.
Shan L; Department of Social Medicine, School of Health Management, Harbin Medical University, Heilongjiang, China.
Zhou Y; Science and Technology Development Center of the Chinese Pharmaceutical Association, Peking, China.
Liu G; Department of Acupuncture, Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Zhu H; Department of Social Medicine, School of Health Management, Harbin Medical University, Heilongjiang, China.; Department of Pharmaceutical Administration, School of Humanities and Social Sciences, Harbin Medical University, Heilongjiang, China.
Wu Q; Department of Social Medicine, School of Health Management, Harbin Medical University, Heilongjiang, China. .
Cui Y; Department of Social Medicine, School of Health Management, Harbin Medical University, Heilongjiang, China. .
Kang Z; Department of Social Medicine, School of Health Management, Harbin Medical University, Heilongjiang, China.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2024 Jan 17; Vol. 24 (1), pp. 90. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/therapeutic use
Insurance*
Nitrosamines*
Humans ; Negotiating ; Interrupted Time Series Analysis ; Health Expenditures ; China ; Drug Costs
Czasopismo naukowe
Tytuł:
Price negotiation and pricing of anticancer drugs in China: An observational study.
Autorzy:
Zhou J; HEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.; Institute for Healthy Cities and West China Research Center for Rural Health Development, Sichuan University, Chengdu, China.
Lan T; HEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.; Institute for Healthy Cities and West China Research Center for Rural Health Development, Sichuan University, Chengdu, China.
Lu H; School of Public Health, Imperial College London, London, United Kingdom.
Pan J; HEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.; School of Public Administration, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2024 Jan 02; Vol. 21 (1), pp. e1004332. Date of Electronic Publication: 2024 Jan 02 (Print Publication: 2024).
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Antineoplastic Agents*/therapeutic use
Breast Neoplasms*
Humans ; Child ; Female ; Negotiating ; Quality of Life ; Costs and Cost Analysis ; Drug Costs ; Pharmaceutical Preparations
Czasopismo naukowe
Tytuł:
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs.
Autorzy:
Wong WB; Genentech, Inc., South San Francisco, CA, United States of America.
Seetasith A; Genentech, Inc., South San Francisco, CA, United States of America.
Hung A; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, NC, United States of America.; Duke-Margolis Center for Health Policy, Durham, NC, United States of America.
Zullig LL; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, NC, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jan 19; Vol. 18 (1), pp. e0280570. Date of Electronic Publication: 2023 Jan 19 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Costs*
Health Expenditures*
Medication Adherence*
Humans ; Hepatitis C/drug therapy ; Retrospective Studies ; Sofosbuvir/therapeutic use
Czasopismo naukowe
Tytuł:
Strategies of drugs cost containment in hospital: A systematic literature review.
Autorzy:
Koushki MS; PhD Student in Health Services Management, Faculty of Management and Medical Informatics, Kerman University of Medical Sciences, Kerman, Iran.
Goudarzi R; Assistant Professor in Health Economic, Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Amiresmaili M; Professor in Health Services Management, Faculty of Management and Medical Informatics, Kerman University of Medical Sciences, Kerman, Iran.
Nekooei Moghaddam M; Professor in Health Services Management, Faculty of Management and Medical Informatics, Kerman University of Medical Sciences, Kerman, Iran.
Yazdi-Feyzabadi V; Assistant Professor in Health Policy, Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Talebian A; Department of Medical Library and Information, School of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Pokaż więcej
Źródło:
The International journal of health planning and management [Int J Health Plann Manage] 2023 Jan; Vol. 38 (1), pp. 7-21. Date of Electronic Publication: 2022 Sep 13.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Hospitals*
Drug Costs*
Humans ; Cost Control ; Health Personnel ; Hospital Costs
Czasopismo naukowe
Tytuł:
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies.
Autorzy:
Kakani P; Harvard University.
Chernew M; Harvard University.
Chandra A; Harvard University.
Pokaż więcej
Źródło:
Journal of health politics, policy and law [J Health Polit Policy Law] 2022 Dec 01; Vol. 47 (6), pp. 629-648.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Drug Costs*
Pharmacies*
United States ; Humans ; Commerce ; Marketing ; Pharmaceutical Preparations
Czasopismo naukowe
Tytuł:
International Reference Pricing in the Context of US Drug Policy.
Autorzy:
Frank R; Harvard University.
Conti RM; Boston University.
Gruber J; Massachusetts Institute of Technology.
Pokaż więcej
Źródło:
Journal of health politics, policy and law [J Health Polit Policy Law] 2022 Dec 01; Vol. 47 (6), pp. 779-796.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Costs*
Medicare*
Aged ; Humans ; United States ; Costs and Cost Analysis ; Public Policy ; Economic Competition ; Drug Industry
Czasopismo naukowe
Tytuł:
The actual status of drug prices and adjustment factors for drug price calculation: an analysis of ultra-orphan drug development in Japan.
Autorzy:
Kawakami A; Cooperative Major in Advanced Biomedical Sciences, Joint Graduate School of Tokyo Women's Medical University and Waseda University, 8-1 Kawadacho, Shinjuku-ku, Tokyo, Japan.; Healthcare and Wellness Division, Mitsubishi Research Institute, Inc., 10-3 Nagatacho 2-Chome, Chiyoda-ku, Tokyo, Japan.
Masamune K; Cooperative Major in Advanced Biomedical Sciences, Joint Graduate School of Tokyo Women's Medical University and Waseda University, 8-1 Kawadacho, Shinjuku-ku, Tokyo, Japan. .
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2022 Nov 08; Vol. 17 (1), pp. 408. Date of Electronic Publication: 2022 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Costs*
Drug Development*/economics
Orphan Drug Production*/economics
Rare Diseases*/drug therapy
Rare Diseases*/economics
Humans ; Japan ; Commerce ; Health Services Needs and Demand/economics
Czasopismo naukowe
Tytuł:
Does India need a new pharmaceutical policy? Examining the implications of the drug price control order.
Autorzy:
Kumar R; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Joshi MM; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Palod RJ; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Dharmagadda S; Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Pokaż więcej
Źródło:
The International journal of health planning and management [Int J Health Plann Manage] 2022 Nov; Vol. 37 (6), pp. 3028-3038. Date of Electronic Publication: 2022 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Drug and Narcotic Control*
Drug Costs*
Drugs, Generic ; Costs and Cost Analysis ; Social Welfare
Czasopismo naukowe
Tytuł:
The Effects of Cost Containment and Price Policies on Pharmaceutical Expenditure in South Korea.
Autorzy:
Kim W; Korea Institute of Public Finance, Sejong, South Korea.
Koo H; College of Pharmacy, Yonsei Institute of Pharmaceutical Research, Yonsei University, Seoul, South Korea.
Lee HJ; College of Pharmacy, Woosuk University, Wanju, South Korea.
Han E; College of Pharmacy, Yonsei Institute of Pharmaceutical Research, Yonsei University, Seoul, South Korea.
Pokaż więcej
Źródło:
International journal of health policy and management [Int J Health Policy Manag] 2022 Oct 19; Vol. 11 (10), pp. 2198-2207. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji:
Journal Article
MeSH Terms:
Health Expenditures*
Drug Costs*
Humans ; Cost Control/methods ; Policy ; Republic of Korea ; Pharmaceutical Preparations
Czasopismo naukowe
Tytuł:
Pharmacy and neighborhood-level variation in cash price of diabetes medications in the United States.
Autorzy:
Warraich HJ; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
Siddiqi HK; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States of America.
Li DG; GoodRx Inc, Santa Monica, CA, United States of America.
van Meijgaard J; GoodRx Inc, Santa Monica, CA, United States of America.
Vaduganathan M; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 07; Vol. 18 (12), pp. e0294164. Date of Electronic Publication: 2023 Dec 07 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Pharmacies*
Pharmacy*
Diabetes Mellitus*/drug therapy
Insulins*
Humans ; United States ; Drug Costs ; Drugs, Generic ; Hypoglycemic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada.
Autorzy:
D'Aiuto C; Department of Community Health Sciences, Faculty of Medicine and Health Sciences, University of Sherbrooke (Longueuil campus), 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada.; Charles-Le Moyne Research Center (CR-CLM), 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada.
Lunghi C; Department of Health Sciences, Université du Québec à Rimouski (Lévis campus), 1595 Boulevard Alphonse-Desjardins, Lévis, QC, G6V 0A6, Canada.; Population Health and Optimal Health Practices Research Unit, CHU de Québec Research Center, 1050 Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada.; Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, 40126, Bologna, BO, Italy.
Guénette L; Population Health and Optimal Health Practices Research Unit, CHU de Québec Research Center, 1050 Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada.; Faculty of Pharmacy, Laval University, 1050 Av. de La Médecine, Québec City, QC, G1V 0A6, Canada.
Berbiche D; Department of Community Health Sciences, Faculty of Medicine and Health Sciences, University of Sherbrooke (Longueuil campus), 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada.; Charles-Le Moyne Research Center (CR-CLM), 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada.
Bertrand K; Department of Community Health Sciences, Faculty of Medicine and Health Sciences, University of Sherbrooke (Longueuil campus), 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada.; Charles-Le Moyne Research Center (CR-CLM), 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada.
Vasiliadis HM; Department of Community Health Sciences, Faculty of Medicine and Health Sciences, University of Sherbrooke (Longueuil campus), 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada. .; Charles-Le Moyne Research Center (CR-CLM), 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada. .
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Nov 24; Vol. 23 (1), pp. 1295. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Journal Article
MeSH Terms:
Analgesics, Opioid*/therapeutic use
Opioid-Related Disorders*/drug therapy
Humans ; Aged ; Potentially Inappropriate Medication List ; Canada ; Health Care Costs ; Drug Costs ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature.
Autorzy:
Patikorn C; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Taychakhoonavudh S; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Sakulbumrungsil R; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Ross-Degnan D; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Landmark Center, Boston, MA, USA.
Anantachoti P; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Źródło:
International journal of health policy and management [Int J Health Policy Manag] 2022 Sep 01; Vol. 11 (9), pp. 1625-1634. Date of Electronic Publication: 2021 Sep 22.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Antineoplastic Agents*/therapeutic use
Drug Costs*
Humans ; Costs and Cost Analysis
Czasopismo naukowe
Tytuł:
Antifungal drug price increases in the United States, 2000-2019.
Autorzy:
Thomas CM; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Shae W; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.
Koestler D; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.
DeFor T; HealthPartners Institute, Bloomington, Minnesota, USA.
Bahr NC; Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Alpern JD; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; HealthPartners Institute, Bloomington, Minnesota, USA.
Pokaż więcej
Źródło:
Mycoses [Mycoses] 2022 Sep; Vol. 65 (9), pp. 859-865. Date of Electronic Publication: 2022 Jul 18.
Typ publikacji:
Journal Article
MeSH Terms:
Antifungal Agents*/therapeutic use
Drug Costs*
Humans ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł:
Adjusting vasopressin availability and formulation: A cost-savings initiative.
Autorzy:
Sizemore S; Emory Healthcare, Atlanta, GA, USA.
Patel MVB; Emory Healthcare, Atlanta, GA, USA.
Carter B; Emory Healthcare, Atlanta, GA, USA.
Garrett E; Emory Healthcare, Atlanta, GA, USA.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Aug 19; Vol. 79 (Suppl 3), pp. S74-S78.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Costs*
Pharmaceutical Services*
Academic Medical Centers ; Adult ; Cost Savings ; Humans ; Vasopressins
Czasopismo naukowe
Tytuł:
Hospitals rely on 340B for patient care.
Autorzy:
Traynor K
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Aug 05; Vol. 79 (16), pp. 1304-1305.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Costs*
Prescription Drugs*
Hospitals ; Humans ; Patient Care ; United States
Czasopismo naukowe
Tytuł:
Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis.
Autorzy:
Huang C; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Ung COL; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
Wushouer H; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.; Center for Strategic Studies, Chinese Academy of Engineering, Beijing, China.
Bai L; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Li X; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Guan X; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Shi L; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Pokaż więcej
Źródło:
International journal of health policy and management [Int J Health Policy Manag] 2022 Aug 01; Vol. 11 (8), pp. 1489-1495. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Costs*
Negotiating*
Humans ; Interrupted Time Series Analysis ; Gefitinib ; China
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies